TrademarkDir
GBIM
DEAD

Serial Number

85603815

Owner

GLOBEIMMUNE, INC.

Attorney

Sabrina C Stavish

First Use Date

Apr 13, 2015

Filing Date

Apr 20, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GBIM Trademark

Serial Number: 85603815 • Registration: 4748281

GBIM is a trademark filed by GLOBEIMMUNE, INC. on April 20, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

GLOBEIMMUNE, INC. (8 trademarks)

1450 Infinite Drive
Louisville, CO 80027

Entity Type: 03

Trademark Details

Filing Date

April 20, 2012

Registration Date

June 2, 2015

First Use Anywhere

April 13, 2015

First Use in Commerce

April 13, 2015

Published for Opposition

March 5, 2013

Cancellation Date

December 12, 2025

Goods & Services

[ Immunotherapy products, namely, pharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines ]

Research and development of immunotherapy products, pharmaceutical products, and vaccine products for others

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Dec 12, 2025 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 2, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 11, 2020 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 11, 2020 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 31, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 11, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 2, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 29, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 28, 2015 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 27, 2015 SUPC
USE AMENDMENT FILED
Apr 23, 2015 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 23, 2015 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2014 EXRA
SOU EXTENSION 3 GRANTED
Nov 12, 2014 EX3G
SOU EXTENSION 3 FILED
Oct 30, 2014 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 30, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2014 EXRA
SOU EXTENSION 2 GRANTED
Apr 23, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 22, 2014 AITU
SOU EXTENSION 2 FILED
Apr 2, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 2, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 12, 2013 EXRA
SOU EXTENSION 1 GRANTED
Oct 9, 2013 EX1G
SOU EXTENSION 1 FILED
Oct 9, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 9, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 30, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 5, 2013 NPUB
PUBLISHED FOR OPPOSITION
Mar 5, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 13, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 28, 2013 PREV
ASSIGNED TO LIE
Jan 26, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 14, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2012 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2012 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2012 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Apr 28, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2012 NWOS
NEW APPLICATION ENTERED
Apr 24, 2012 NWAP

Related Trademarks

More from this Owner

TARGETED MOLECULAR IMMUNOTHERAPY

TARGETED MOLECULAR IMMUNOTHERAPY

TARGETED MOLECULAR IMMUNOTHERAPY

TARGETED MOLECULAR IMMUNOTHERAPY

TARGETED MOLECULAR IMMUNOTHERAPY

TARGETED MOLECULAR IMMUNOTHERAPY

TAME

TAME

TAME

TAME

GLOBEIMMUNE

GLOBEIMMUNE